Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

[Epidemiological characteristics of multiple sclerosis in the Kabardino-Balkaria Republic.]
The Nuclear IκB Family Protein IκBNS Influences the Susceptibility to Experimental Autoimmune Encephalomyelitis in a Murine Model.
3D+t Brain MRI segmentation using robust 4D Hidden Markov Chain.
Towards a better understanding of pseudoatrophy in the brain of multiple sclerosis patients.
Relationship between Sleep Quality and Quality of Life in Patients with Multiple Sclerosis.
Thymic stromal lymphopoietin deficiency attenuates experimental autoimmune encephalomyelitis.
Meta-analysis of the IL23R and IL12B polymorphisms in multiple sclerosis.
A systematic review of drugs in late-stage development for the treatment of multiple sclerosis: a focus on oral synthetic drugs.
Neuromyelitis optica spectrum disorder associated with osmotic demyelination syndrome.
Chronic Severe Hyponatremia and Cardiopulmonary Bypass: Avoiding Osmotic Demyelination Syndrome.
Dietary phytochemicals and neuro-inflammaging: from mechanistic insights to translational challenges.
Care patterns in multiple sclerosis: principal care, comprehensive team care, consortium care.
Measuring the Impact of Multiple Sclerosis: Enhancing the Performance of the Msis-29 and Msws-12.
Changes in brain functional connectivity patterns are driven by an individual lesion in MS: a resting-state fMRI study.
Translational utility of experimental autoimmune encephalomyelitis: recent developments.
[Clinical outcome of the hyperacute form of acute disseminated encephalomyelitis.]
Effect of occupation on risk of developing MS: an insurance cohort study.
SIRT1 Promotes RGC Survival and Delays Loss of Function Following Optic Nerve Crush.
Headaches in multiple sclerosis patients might imply an inflammatorial process.
Requirement for safety monitoring for approved MS therapies - An overview.
Determination of Brain Volumes Using Quantitative MR Imaging in Patients with Multiple Sclerosis.
IMMUNE SYSTEM INDUCTION OF NERVE GROWTH FACTOR IN AN ANIMAL MODEL OF MULTIPLE SCLEROSIS: IMPLICATIONS IN RE-MYELINATION AND MYELIN REPAIR.
Will CSF biomarkers guide future therapeutic decisions in multiple sclerosis?
[Use of vitamins for correction of the functional state of cytochrome P450 systems at experimental allergic encephalomyelitis].
Diagnosis of asymptomatic natalizumab-associated PML: are we between a rock and a hard place?

Pages